CHEMBL417119http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfCHEMBL3508152Doxorubicinol aglyconeHomo sapiens1Fig. 2, p.19CHEMBL3508141Epidoxorubicinol, 4'-epiadriamycinol9606CHEMBL417120http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfCHEMBL35081447d-AonHomo sapiens1Fig. 2, p.19CHEMBL417Epirubicin9606CHEMBL417121http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfCHEMBL3508153Doxorubicin aglyconeHomo sapiens1Fig. 2, p.19CHEMBL417Epirubicin9606CHEMBL417122http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfCHEMBL6067664Epirubicin glucuronideHomo sapiens1Fig. 2, p.19CHEMBL417Epirubicin9606CHEMBL417123http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfCHEMBL3508141Epidoxorubicinol, 4'-epiadriamycinolHomo sapiens1Fig. 2, p.19CHEMBL417Epirubicin9606CHEMBL417124http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfCHEMBL6067664Epirubicinol glucuronideHomo sapiens1Fig. 2, p.19CHEMBL3508141Epidoxorubicinol, 4'-epiadriamycinol9606CHEMBL417125http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfCHEMBL35081437d-AolonHomo sapiens1Fig. 2, p.19CHEMBL3508141Epidoxorubicinol, 4'-epiadriamycinol9606CHEMBL1639O-dealkylation127http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdfhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdfCHEMBL3507701Metabolite M4Homo sapiens3Fig. 9, p164/165CHEMBL1639Aliskiren, SPP1009606CHEMBL1639O-demethylation of the methoxypropoxy side chain128http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfCHEMBL3507701Metabolite M4Callithrix jacchus2Fig. 2.1.4.1, p.46CHEMBL1639Aliskiren, SPP1009483CHEMBL1639Oxidative dealkylation129http://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/99/50-778_Ellence_biopharmr.pdfCHEMBL3507701Metabolite M4Homo sapiens1Fig. 2, p.19CHEMBL1639Aliskiren, SPP1009606CHEMBL1639Species: Figure legend also mentions Rattus norvegicus.130http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfCHEMBL3507701Metabolite M4Mus musculus1Fig. 2.1.1.1, p.35CHEMBL3507700Metabolite M310090CHEMBL1639Species: Figure legend also mentions Rattus norvegicus.131http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfCHEMBL3507701Metabolite M4Mus musculus1Fig. 2.1.1.1, p.35CHEMBL3507697Metabolite M210090CHEMBL1639Species: Figure legend also mentions Rattus norvegicus.C-oxidation132http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfCHEMBL3507697Metabolite M2Mus musculus1Fig. 2.1.1.1, p.35CHEMBL3507700Metabolite M310090CHEMBL1639Oxidation133http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfCHEMBL3507697Metabolite M2Callithrix jacchus2Fig. 2.1.4.1, p.46CHEMBL3507700Metabolite M39483CHEMBL1639Oxidation134http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdfhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdfCHEMBL3507697Metabolite M2Homo sapiens3Fig. 9, p164/165CHEMBL3507700Metabolite M39606CHEMBL1639Species: Figure legend also mentions Rattus norvegicus.135http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfCHEMBL3507697Metabolite M2Mus musculus1Fig. 2.1.1.1, p.35CHEMBL1639Aliskiren, SPP10010090CHEMBL1639Species: Figure legend also mentions Rattus norvegicus.Glucuronidation136http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfCHEMBL3507696Metabolite M5Mus musculus1Fig. 2.1.1.1, p.35CHEMBL3507699Metabolite M110090CHEMBL1639Species: Figure legend also mentions Rattus norvegicus.Glucuronidation137http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_PharmR_P2.pdfCHEMBL3507695Metabolite M6Mus musculus1Fig. 2.1.1.1, p.35CHEMBL3507701Metabolite M410090CHEMBL1639O-glucuronidation138http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdfhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdfCHEMBL3507695Metabolite M6Homo sapiens3Fig. 9, p164/165CHEMBL3507701Metabolite M49606CHEMBL1639139http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P2.pdfhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdfOTHERhttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000_ClinPharmR_P3.pdfCHEMBL3507701Metabolite M4Homo sapiens3Fig. 9, p164/165CHEMBL3507697Metabolite M2960620/chembl/api/data/metabolism?limit=20&offset=202147